Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Topics:
Hematologic Malignancies
•
Medical Oncology
•
Lymphoma
•
Hematology
How do you counsel young patients undergoing cladribine therapy for hairy cell leukemia in terms of risk of secondary malignancy and infertility?
Related Questions
How would you manage an asymptomatic elderly frail patient with newly diagnosed mantle cell lymphoma with TP53 mutation?
Would you recommend allogeneic stem cell transplantation for consolidation in a patient with follicular lymphoma who relapsed within 13 months of initial chemo-immunotherapy?
How do you sequence therapy in an older patient with newly-diagnosed blastoid mantle cell lymphoma with a 17p deletion?
How do you treat ALK+ large B cell lymphoma in a young fit patient?
How do you consider infectious risk from COVID-19 in your choice for frontline treatment of low-grade advanced-stage follicular lymphoma?
How would you manage a patient with history of follicular lymphoma treated with Bendamustine-Rituximab who now has a new FDG avid lesion that is biopsy proven CD30 positive CD20 negative DLBCL?
What is the optimal treatment for a fit, elderly patient with NGC diffuse large B cell lymphoma that recurred about 1 year after dose-attenuated R-CHOP?
What are the scenarios where you would do a BM biopsy for indolent lymphomas?
How will you use Pola-R-CHP in the frontline treatment of DLBCL?
How would one approach NK / T cell, nasal type lymphoma with CNS and ocular involvement who is not a candidate for high dose methotrexate?
